Degradation of Polo-like Kinase 1 by the Novel Poly-Arginine N-Degron Pathway PROTAC Regulates Tumor Growth in Nonsmall Cell Lung Cancer
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- JOURNAL OF MEDICINAL CHEMISTRY67(5) · pp.3307 · 2024
- 피인용
- Web of Science 26Scopus 26
- FWCI (Scopus)
- 2.73
- JCR IF
- JCR 2023 6.9
- ISSN
- 0022-2623
저자
- Gunasekaran, Pethaiah제1저자Korea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
- Hwang, Yeon SilKorea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
- Lee, Gong-HyeonDandicure Inc, Ochang 28119, Chungbuk, South Korea
- Park, JaehuiChungbuk Natl Univ, Coll Pharm, Cheongju 28160, Chungbuk, South Korea
- Kim, Jung GiKorea Res Inst Biosci & Biotechnol, Nucl Acid Therapeut Res Ctr, Cheongwon 28116, Chungbuk, South Korea
- La, Yeo KyungKorea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
- Park, Nam YeongKorea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
- Kothandaraman, RajeshDandicure Inc, Ochang 28119, Chungbuk, South Korea
- Yim, Min SuKorea Dis Control & Prevent Agcy, Natl Inst Hlth, Ctr Vaccine Res, Div Vaccine Dev Coordinat,Natl Inst Infect Dis, Cheongju 28159, South Korea
- Choi, JoonhyeokKorea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
- Kim, Hak NamKorea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
- Park, Il YeongChungbuk Natl Univ, Coll Pharm, Cheongju 28160, Chungbuk, South Korea
- Lee, Soo JaeChungbuk Natl Univ, Coll Pharm, Cheongju 28160, Chungbuk, South Korea
- 김미현교신저자Pusan Natl Univ, Dept Internal Med, Sch Med, Busan 49241, South Korea
- Cha-Molstad, Hyunjoo교신저자Korea Res Inst Biosci & Biotechnol, Nucl Acid Therapeut Res Ctr, Cheongwon 28116, Chungbuk, South Korea
- Shin, Song Yub교신저자Chosun Univ, Dept Cellular & Mol Med, Sch Med, Gwangju 61452, South Korea
- Ryu, Eun Kyoung교신저자Korea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
- Bang, Jeong Kyu교신저자Korea Basic Sci Inst KBSI, Div Magnet Resonance, Ochang 28119, Chungbuk, South Korea
초록
Polo-like kinase 1 (PLK1), which is crucial in cell cycle regulation, is considered a promising anticancer drug target. Herein, we present the N-degron pathway-based proteolysis targeting chimera (PROTAC) for PLK1 degradation, targeting the Polo-box domain (PBD). We identified DD-2 as the most potent PROTAC that selectively induces PLK1 degradation in cancer cells, including HeLa and nonsmall cell lung cancer (NSCLC), through the N-degron pathway. DD-2 exhibited significant in vitro anticancer effects, inducing G2/M arrest and apoptosis in HeLa and NSCLC cell lines. DD-2 showed significant tumor growth inhibition in a xenograft mouse model using HeLa and NSCLC cell lines, highlighting its potential in cancer treatment. Furthermore, the combination of DD-2 with tyrosine kinase inhibitor (TKI), osimertinib, effectively suppressed tumor growth in double-mutated H1975 cell lines, emphasizing DD-2’s potential in combination cancer therapies. Collectively, this study demonstrates the potential of the N-degron pathway, especially using DD-2, for targeted cancer therapies.
키워드
SMALL-MOLECULE INHIBITORE3 UBIQUITIN LIGASEEND RULE PATHWAYBOX DOMAINTARGETPLK1COMPLEXIDENTIFICATIONBI-2536BINDING
식별자
- Scopus EID
- 2-s2.0-85180960077
- WoS UID
- 001158875000001



로그인
연구물 목록으로